|
1
|
Juillerat P, Grueber MM, Ruetsch R, Santi G, Vuillèmoz M, Michetti P. Positioning biologics in the treatment of IBD: A practical guide – Which mechanism of action for whom? Current Research in Pharmacology and Drug Discovery 2022; 3:100104. [PMID: 35570855 PMCID: PMC9092374 DOI: 10.1016/j.crphar.2022.100104] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2022] [Revised: 04/04/2022] [Accepted: 04/24/2022] [Indexed: 12/30/2022] Open
Abstract
The number of available biological therapies have doubled over the last 10 years and the arrival of novel molecules (interleukin 23p19 inhibitors) is ongoing alongside the development of small molecules. As a result of this vast landscape of treatment, positioning advanced therapies (according to clinical situation, efficacy and safety) is of paramount importance to providing personalized, appropriate IBD treatment. In this publication the recent available literature is summarized for practical integration into clinical practice including comparative efficacy data, patient and disease demographics. We refer to recent publications and expert opinion in order to facilitate the decision making process of positioning biologicals IBD treatment.
Collapse
Affiliation(s)
- Pascal Juillerat
- Gastroenterology, Clinic for Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
- Crohn and Colitis Center, Gastro-entérologie Beaulieu SA, Lausanne, Switzerland
- Corresponding author. Clinic for Visceral Surgery and Medicine Inselspital, Bern University Hospital Freiburgstrasse 10, CH-3010, Bern, Switzerland.
| | - Maude Martinho Grueber
- Gastroenterology, Clinic for Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
- Crohn and Colitis Center, Gastro-entérologie Beaulieu SA, Lausanne, Switzerland
| | - Roseline Ruetsch
- Crohn and Colitis Center, Gastro-entérologie Beaulieu SA, Lausanne, Switzerland
| | - Giulia Santi
- Gastroenterology, Clinic for Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - Marianne Vuillèmoz
- Crohn and Colitis Center, Gastro-entérologie Beaulieu SA, Lausanne, Switzerland
| | - Pierre Michetti
- Crohn and Colitis Center, Gastro-entérologie Beaulieu SA, Lausanne, Switzerland
- Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
| |
Collapse
|
|
2
|
Ruetsch R, Juillerat P, Flatz A, von Elm E. [Does long-term use of proton pump inhibitors promote premalignant lesions of the gastric mucosa?]. Praxis (Bern 1994) 2016; 105:221-222. [PMID: 26886699 DOI: 10.1024/1661-8157/a002262] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- Roseline Ruetsch
- 1 Universitätsklinik für Viszerale Chirurgie und Medizin, Gastroenterologie, Inselspital, Universitätsspital Bern
| | - Pascal Juillerat
- 1 Universitätsklinik für Viszerale Chirurgie und Medizin, Gastroenterologie, Inselspital, Universitätsspital Bern
| | - Aline Flatz
- 2 Cochrane Schweiz, Institut universitaire de médecine sociale et préventive, Lausanne
| | - Erik von Elm
- 2 Cochrane Schweiz, Institut universitaire de médecine sociale et préventive, Lausanne
| |
Collapse
|
|
3
|
Derdau V, Atzrodt J, Markó IE, Harwood SJ, Moenius T, Salter R, Wietfeld B, Burtscher P, Zueger C, Clayden J, Salter R, Bordeaux K, Burtscher P, Metz Y, Moenius T, Rodriguez I, Ruetsch R, Voges R, Zueger C, Gardiner JM, Stimpson W, Panchal N, Herbert J, Ellames GJ, Beller M, Kozempel J, Kadeřávek J, Lešetický L, Lebeda O, Wähälä K, Kiuru P, Leppälä E, Pohjoispää M, Parikka K, Raffaelli B, Herbert JM, Janssen CGM, Verluyten WLM, Vliegen M, Mäding P, Füchtner F, Bergmann R, Pietzsch J, Hultsch C, Wüst F, Scheunemann M, Vercouillie J, Fischer S, Sorger D, Großmann U, Schliebs R, Sabri O, Steinbach J. 13th Workshop of the Central European Division e.V. of the International Isotope Society. J Labelled Comp Radiopharm 2006. [DOI: 10.1002/jlcr.1020] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
|
4
|
Pounds S, Hickey MJ, Kingston LP, Mather AN, Wilkinson DJ, Sidorov GV, Zverkov YB, Myasoedov NF, Karpenko IL, Shirokova EA, Yanvarev DM, Yasko MV, Skoblov YS, Susan AB, Myasoedov NF, Nagaev IY, Shevchenko VP, Susan AB, Rotert G, Krüger J, Fels G, Wuest F, Mäding P, Zessin J, Pleiß U, Wüst F, Bloom AJ, Derdau V, Oekonomopulos R, Schubert G, Andres H, Burtscher P, Metz Y, Moenius T, Kaegi F, Metz Y, Rodriguez I, Ruetsch R, Janssen CGM, Verreet B, Lenoir HAC, Thijssen JBA, Stuerm RP, Krins A, Rausch E, Breyer M, Hucke K, Gaefke D, Schmeer K. 11th conference of the central european division e.V. of the international isotope society. J Labelled Comp Radiopharm 2004. [DOI: 10.1002/jlcr.814] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|